Uncertain Biogen Applying to Sell MS Drug for Crohn's RedNova Mon, 18 Dec 2006 10:05 AM PST By Jeffrey Krasner, The Boston Globe Dec. 16--Biogen Idec Inc. and Elan Corp. said yesterday that they have applied to the Food and Drug Administration for approval to sell Tysabri, a multiple sclerosis drug, to treat patients with Crohn's disease.

Health calendar Gloucester Daily Times Mon, 18 Dec 2006 9:25 AM PST *Mondays, 10 to 11 a.m., Tai chi with Meredith Morgan. *Tuesdays, 9:45 to 11 a.m., Yoga with Mary Ann Wenniger. *Wednesdays, 12:30 to 1:30 p.m., Chair Yoga with Nana Dunn.

'It was the start of a very different life'
Guardian Unlimited Mon, 18 Dec 2006 0:51 AM PST
Michelle Mullen had it all: good job, money, and a busy social life. Then she went to her doctor with numbness and blurred vision, and everything changed ...